NASDAQ:INKT | Free Cash Flow | MiNK Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.73M
2025-12-31-$2.07M
2025-03-31-$1.34M
2024-12-31-$1.73M
2024-03-31-$2.54M
2023-12-31-$3.04M$0.00-$3.04M
2023-03-31-$4.37M$13,500.00-$4.38M
2022-12-31-$4.43M$127,838.00-$4.56M
2022-03-31-$4.2M
2021-12-31-$1.7M-$277.00-$1.7M
2021-03-31-$4.21M$39,520.00-$4.25M
2020-12-31-$1.72M$0.00-$1.72M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.93M
2024-12-31-$9.56M
2023-12-31-$15.76M$73,561.00-$15.84M
2022-12-31-$18.87M$250,046.00-$19.12M
2021-12-31-$12.83M$248,983.00-$13.08M
2020-12-31-$8.34M$95,212.00-$8.43M